Search research articles
Contact Us
Filters
Showing results (11-20 of 106) with videos related to
Page
of 11
Sort By:
American Journal of Public Health
|
February 7, 1998
Of floors and ceilings--defining, assuring, and communicating vaccine safety
R F Breiman, J A Zanca
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports
|
December 8, 2004
Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation
A S Postema, R F Breiman,
The Journal of Experimental Medicine
|
March 1, 1987
Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens
R F Breiman, M A Horwitz
Lancet (London, England)
|
November 10, 1990
Changing epidemiology of group A streptococcal infection in the USA
B Schwartz, R R Facklam, R F Breiman
American Journal of Public Health
|
August 1, 1992
Imported leprosy in the United States, 1978 through 1988: an epidemic without secondary transmission
T D Mastro, S C Redd, R F Breiman
Emerging Infectious Diseases
|
April 1, 1995
Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group
M S Cetron, D B Jernigan, R F Breiman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2001
Challenges in the development, licensure, and use of combination vaccines
A S Postema, M G Myers, R F Breiman
JAMA
|
January 17, 1996
Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group
J F Plouffe, R F Breiman, R R Facklam
Archives of Internal Medicine
|
November 14, 1994
Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality
B J Marston, H B Lipman, R F Breiman
JAMA
|
January 17, 1996
Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group
D B Jernigan, M S Cetron, R F Breiman
Page
of 11
Search research articles
Search
Showing results (11-20 of 106) with videos related to
Sort By:
Page
of 11
American Journal of Public Health
|
February 7, 1998
Of floors and ceilings--defining, assuring, and communicating vaccine safety
R F Breiman, J A Zanca
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports
|
December 8, 2004
Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation
A S Postema, R F Breiman,
The Journal of Experimental Medicine
|
March 1, 1987
Guinea pigs sublethally infected with aerosolized Legionella pneumophila develop humoral and cell-mediated immune responses and are protected against lethal aerosol challenge. A model for studying host defense against lung infections caused by intracellular pathogens
R F Breiman, M A Horwitz
Lancet (London, England)
|
November 10, 1990
Changing epidemiology of group A streptococcal infection in the USA
B Schwartz, R R Facklam, R F Breiman
American Journal of Public Health
|
August 1, 1992
Imported leprosy in the United States, 1978 through 1988: an epidemic without secondary transmission
T D Mastro, S C Redd, R F Breiman
Emerging Infectious Diseases
|
April 1, 1995
Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group
M S Cetron, D B Jernigan, R F Breiman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 26, 2001
Challenges in the development, licensure, and use of combination vaccines
A S Postema, M G Myers, R F Breiman
JAMA
|
January 17, 1996
Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group
J F Plouffe, R F Breiman, R R Facklam
Archives of Internal Medicine
|
November 14, 1994
Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality
B J Marston, H B Lipman, R F Breiman
JAMA
|
January 17, 1996
Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group
D B Jernigan, M S Cetron, R F Breiman
Page
of 11